Stocks
GlaxoSmithKline (GSK) OPEX US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| OPEX, £ | 13 337 000 000 | 13 337 000 000 | 13 337 000 000 | 15 377 000 000 | 14 259 000 000 | 18 113 000 000 | |||
| Changes by years, y/y, % | -18% | 0% | 0% | +15% | -7% | -1.1% | |||
GlaxoSmithKline. OPEX, £
GlaxoSmithKline. OPEX, changes, %
GlaxoSmithKline. OPEX, sum by quarters, £
GlaxoSmithKline (GSK) OPEX US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q1 | 2024Q3 | 2024Q2 | 2024Q3 | LTM ? | |||
| OPEX, £ | 3 818 000 000 | 3 443 000 000 | 5 426 000 000 | 3 818 000 000 | 5 426 000 000 | 18 113 000 000 | ||
| Changes by years, y/y, % | +23% | +18% | +38% | +23% | +38% | |||
| Changes by quarters, q/q, % | -18% | -10% | +58% | -30% | +42% | |||
